Your search "COVID" returned 58 publications
Publications 1-10 of 58
-
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations
Rua, C., Raman, B., Rodgers, C., Newcombe, V., Manktelow, A., Chatfield, D., et al.
Brain: A Journal of Neurology
-
Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction
Wood, G., Sargent, B., Ahmad, Z., Tharmaratnam, K., Dunai, C., Egbe, F., et al.
Nature Medicine
-
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID
Hurler, L., Mescia, F., Bergamaschi, L., Kajdácsi, E., Sinkovits, G., et al.
iScience
-
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study
van Wamelen, D., Rota, S., Hartmann, M., Martin, N., Alam, A., Thomas, R., et al.
Clinical Medicine (London, England)
-
Proinflammatory cytokines driving cardiotoxicity in COVID-19
Colzani, M., Bargehr, J., Mescia, F., Williams, E., Knight-Schrijver, V., Lee, J., et al.
Cardiovascular Research
-
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
Hanson, A., Mulè, M., Ruffieux, H., Mescia, F., Bergamaschi, L., Pelly, V., et al.
Nature Immunology
-
Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to Long Covid
Krishna, B., Lim, E., Metaxaki, M., Jackson, S., Mactavous, L., et al.
Science Advances
-
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Boston, R., Guan, R., Kalmar, L., Beier, S., Horner, E., Beristain-Covarrubias, N., et al.
Life Science Alliance
-
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Michael, B., Dunai, C., Needham, E., Tharmaratnam, K., Williams, R., Huang, Y., et al.
Nature Communications
-
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study
Liu, Z., Alexander, J., Le, K., Zhou, X., Ibraheim, H., Anandabaskaran, S., et al.
EClinicalMedicine